financetom
Business
financetom
/
Business
/
Antero Resources Insider Sold Shares Worth $528,000, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Antero Resources Insider Sold Shares Worth $528,000, According to a Recent SEC Filing
Mar 20, 2026 1:55 AM

04:40 AM EDT, 03/20/2026 (MT Newswires) -- Benjamin A. Hardesty, Director, on March 19, 2026, sold 12,000 shares in Antero Resources ( AR ) for $528,000. Following the Form 4 filing with the SEC, Hardesty has control over a total of 150,742 common shares of the company, with 150,242 shares held directly and 500 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1433270/000110465926032266/xslF345X05/tm269417-1_4seq1.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Trump sues Wall Street Journal over Epstein report, seeks $10 billion
Trump sues Wall Street Journal over Epstein report, seeks $10 billion
Jul 18, 2025
* Trump denies WSJ report on Epstein birthday letter * U.S. wants Epstein grand jury transcripts made public * Trump supporters demand more Epstein documents * Dow Jones defends accuracy of its reporting (Adds Dow Jones statement, details about lawsuit and context of damages, paragraphs 2, 7-15) By Nandita Bose and Jonathan Stempel WASHINGTON/NEW YORK, July 18 (Reuters) - U.S....
Sarepta says it won't comply with FDA request to stop shipping gene therapy Elevidys
Sarepta says it won't comply with FDA request to stop shipping gene therapy Elevidys
Jul 18, 2025
By Bhanvi Satija (Reuters) -U.S. regulators asked Sarepta Therapeutics ( SRPT ) on Friday to voluntarily halt shipments of its Elevidys gene therapy after a muscular dystrophy patient who received a different, experimental treatment died, but the company said it would not do so. The Food and Drug Administration announced the move, confirming an earlier Reuters report, after making the...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Sarepta says it won't comply with FDA request to stop shipping gene therapy Elevidys
Sarepta says it won't comply with FDA request to stop shipping gene therapy Elevidys
Jul 18, 2025
By Bhanvi Satija (Reuters) -U.S. regulators asked Sarepta Therapeutics ( SRPT ) on Friday to voluntarily halt shipments of its Elevidys gene therapy after a muscular dystrophy patient who received a different, experimental treatment died, but the company said it would not do so. The Food and Drug Administration announced the move, confirming an earlier Reuters report, after making the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved